APA
Ritchie C. W., Chiu E., Harrigan S., Hall K., Hassett A., Macfarlane S., Mastwyk M., O'Connor D. W., Opie J. & Ames D. (20030613). The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia. : International journal of geriatric psychiatry.
Chicago
Ritchie C W, Chiu E, Harrigan S, Hall K, Hassett A, Macfarlane S, Mastwyk M, O'Connor D W, Opie J and Ames D. 20030613. The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia. : International journal of geriatric psychiatry.
Harvard
Ritchie C. W., Chiu E., Harrigan S., Hall K., Hassett A., Macfarlane S., Mastwyk M., O'Connor D. W., Opie J. and Ames D. (20030613). The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia. : International journal of geriatric psychiatry.
MLA
Ritchie C W, Chiu E, Harrigan S, Hall K, Hassett A, Macfarlane S, Mastwyk M, O'Connor D W, Opie J and Ames D. The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia. : International journal of geriatric psychiatry. 20030613.